logo

For the Inventor, By the Inventor

Columbia, MD, United States of America

Peter L Pedersen

This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter L Pedersen. Retrieved from https://idiyas.com/inventor/peter-l-pedersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal2 out of 3,803 
 
Johns Hopkins University
 patents

Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents
1. 8119116 - Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production (2012-02-21),
2. 7547673 - Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production (2009-06-16),

Title: Peter L Pedersen: Innovator in Cancer Therapeutics

Introduction

Peter L Pedersen is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on innovative methods for treating cancerous tumors. His work is particularly relevant in the development of selective inhibitors of ATP production.

Latest Patents

One of his latest patents involves therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production. This invention relates to methods of treating cancerous tumors by utilizing these selective inhibitors. Additionally, it encompasses pharmaceutical preparations that include such inhibitors and outlines methods for administering them directly to a tumor via intraarterial routes. The patent also details methods for identifying compositions that selectively inhibit ATP production for therapeutic use.

Career Highlights

Peter L Pedersen is affiliated with Johns Hopkins University, where he continues to advance research in cancer treatment. His innovative approaches have garnered attention in the scientific community, contributing to the ongoing fight against cancer.

Collaborations

He has collaborated with esteemed colleagues such as Jean-Francois Geschwind and Young He Ko, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Peter L Pedersen's work in cancer therapeutics exemplifies the vital role of innovation in medicine. His patents and collaborations reflect a commitment to improving treatment options for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…